Title: Evaluation of the influence of Id2 protein on prognosis in children with neuroblastoma


The aim of this study was evaluation of the Id2 protein expression in neuroblastoma (NBL), including its influence on overall survival (OS) and disease free survival (DFS) as well as its correlation with known prognostic factors. The analysis of selected prognostic factors and their influence on OS and DFS was performed. In the years 1991-2005, among 100 patients treated for NBL 60 were evaluated. Id2 protein expression was examined by immunohistochemistry on paraffin embedded tumor tissue. All 60 analyzed tumors showed presence of Id2 protein expression. The evaluated tumors differed in the intensity of expression and the percentage of Id2 positive cells. The intensity of expression and percentage of cells had no influence on OS and DFS. There was no correlation with presence of other risk factors. In the whole group and in patients without MYCN amplification it can be supposed that there is a tendency to lower OS in patients with strong Id2 expression in NBL cells (p=0,07 and p=0,08, respectively). In the group without MYCN amplification there was a tendency to higher risk of disease relapse or progression in patients with stronger intensity of Id2 expression (p=0,05). The most important prognostic factors remained MYCN amplification and stage of disease. Although Id2 is not a prognostic factor in NBL, due to its abundant presence in NBL cells may be a potential therapeutic t ; arget.

Place of publishing:


Level of degree:

2 - studia doktoranckie

Degree discipline:

onkologia ; pediatria

Degree grantor:

Wydział Lekarski


Balwierz, Walentyna

Date issued:




Call number:




Access rights:


Object collections:

Last modified:

Jun 26, 2023

In our library since:

Nov 21, 2012

Number of object content hits:

1 351

Number of object content views in PDF format


All available object's versions:


Show description in RDF format:


Show description in OAI-PMH format:


Edition name Date
ZB-109594 Jun 26, 2023


Citation style:

This page uses 'cookies'. More information